WHO launches first trial of antiviral to prevent Bundibugyo strain of Ebola

The World Health Organization launched the first clinical trial to test an antiviral drug's effectiveness in preventing infection from the Bundibugyo strain of Ebola in the Democratic Republic of Congo. The outbreak is spreading beyond known transmission chains despite ongoing response efforts.